Evaluation of Pre-operative Biopsy, Surgical Procedures and Oncologic Outcomes in Upper Tract Urothelial Carcinoma (UTUC)

Purpose: Discordance between pre-operative biopsy and final pathology for Upper Tract Urothelial Carcinoma (UTUC) is high and optimal management remains controversial. The aim of this study is to evaluate the accuracy of pre-operative biopsy, to identify prognostic factors and to evaluate the effect...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Florestan J. Koll, Eva Meisenzahl, Bernhard Haller, Philipp Maisch, Florian Kirchhoff, Thomas Horn, Jürgen E. Gschwend, Sebastian C. Schmid
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/b826d23d0bf04cf0810904123afdf502
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b826d23d0bf04cf0810904123afdf502
record_format dspace
spelling oai:doaj.org-article:b826d23d0bf04cf0810904123afdf5022021-11-30T22:43:50ZEvaluation of Pre-operative Biopsy, Surgical Procedures and Oncologic Outcomes in Upper Tract Urothelial Carcinoma (UTUC)2296-875X10.3389/fsurg.2021.790738https://doaj.org/article/b826d23d0bf04cf0810904123afdf5022021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fsurg.2021.790738/fullhttps://doaj.org/toc/2296-875XPurpose: Discordance between pre-operative biopsy and final pathology for Upper Tract Urothelial Carcinoma (UTUC) is high and optimal management remains controversial. The aim of this study is to evaluate the accuracy of pre-operative biopsy, to identify prognostic factors and to evaluate the effect of adjuvant chemotherapy on survival and oncologic outcome in UTUC.Methods: We analyzed records of patients receiving surgical treatment for UTUC. Pathology of pre-operative biopsy was compared to surgical specimen. We used Kaplan-Meier method to estimate survival probabilities and Cox's proportional hazards models to estimate the association between covariates and event times. Primary endpoint was overall survival (OS). A matched-pair analysis was performed to evaluate the effect of adjuvant chemotherapy.Results: 151 patients underwent surgical treatment (28% open, 36% laparoscopic, 17% robotic radical nephroureterectomy; 14% segmental ureteral resections and 5% palliative nephrectomy) for UTUC and were included in the analysis. Upstaging from <pT1 in endoscopic biopsy to ≥pT1 in final pathology occurred in 61% of patients and upgrading from low-grade to high-grade occurred in 30% of patients. Five-year OS was 59.5%. In the univariate Cox-regression model pathological stage, grade, lymphovascular invasion and positive surgical margins were associated with OS. Matched pair analysis for stage (<pT3; ≥pT3; pN+) and age revealed a significant survival benefit for adjuvant chemotherapy (HR 0.40, 0.14–0.77, p < 0.018) in this cohort.Conclusion: UTUC is often underestimated in pre-operative biopsy, and it is associated with significant mortality. Pathological stage and grade, lymphovascular invasion and lymph node metastases are predictors of oncologic outcome and survival.Florestan J. KollFlorestan J. KollEva MeisenzahlBernhard HallerPhilipp MaischPhilipp MaischFlorian KirchhoffThomas HornJürgen E. GschwendSebastian C. SchmidFrontiers Media S.A.articleadjuvant chemotherapynephroureterectomysegmental ureteral resectionureteroscopyupper tract urothelial carcinomaUTUCSurgeryRD1-811ENFrontiers in Surgery, Vol 8 (2021)
institution DOAJ
collection DOAJ
language EN
topic adjuvant chemotherapy
nephroureterectomy
segmental ureteral resection
ureteroscopy
upper tract urothelial carcinoma
UTUC
Surgery
RD1-811
spellingShingle adjuvant chemotherapy
nephroureterectomy
segmental ureteral resection
ureteroscopy
upper tract urothelial carcinoma
UTUC
Surgery
RD1-811
Florestan J. Koll
Florestan J. Koll
Eva Meisenzahl
Bernhard Haller
Philipp Maisch
Philipp Maisch
Florian Kirchhoff
Thomas Horn
Jürgen E. Gschwend
Sebastian C. Schmid
Evaluation of Pre-operative Biopsy, Surgical Procedures and Oncologic Outcomes in Upper Tract Urothelial Carcinoma (UTUC)
description Purpose: Discordance between pre-operative biopsy and final pathology for Upper Tract Urothelial Carcinoma (UTUC) is high and optimal management remains controversial. The aim of this study is to evaluate the accuracy of pre-operative biopsy, to identify prognostic factors and to evaluate the effect of adjuvant chemotherapy on survival and oncologic outcome in UTUC.Methods: We analyzed records of patients receiving surgical treatment for UTUC. Pathology of pre-operative biopsy was compared to surgical specimen. We used Kaplan-Meier method to estimate survival probabilities and Cox's proportional hazards models to estimate the association between covariates and event times. Primary endpoint was overall survival (OS). A matched-pair analysis was performed to evaluate the effect of adjuvant chemotherapy.Results: 151 patients underwent surgical treatment (28% open, 36% laparoscopic, 17% robotic radical nephroureterectomy; 14% segmental ureteral resections and 5% palliative nephrectomy) for UTUC and were included in the analysis. Upstaging from <pT1 in endoscopic biopsy to ≥pT1 in final pathology occurred in 61% of patients and upgrading from low-grade to high-grade occurred in 30% of patients. Five-year OS was 59.5%. In the univariate Cox-regression model pathological stage, grade, lymphovascular invasion and positive surgical margins were associated with OS. Matched pair analysis for stage (<pT3; ≥pT3; pN+) and age revealed a significant survival benefit for adjuvant chemotherapy (HR 0.40, 0.14–0.77, p < 0.018) in this cohort.Conclusion: UTUC is often underestimated in pre-operative biopsy, and it is associated with significant mortality. Pathological stage and grade, lymphovascular invasion and lymph node metastases are predictors of oncologic outcome and survival.
format article
author Florestan J. Koll
Florestan J. Koll
Eva Meisenzahl
Bernhard Haller
Philipp Maisch
Philipp Maisch
Florian Kirchhoff
Thomas Horn
Jürgen E. Gschwend
Sebastian C. Schmid
author_facet Florestan J. Koll
Florestan J. Koll
Eva Meisenzahl
Bernhard Haller
Philipp Maisch
Philipp Maisch
Florian Kirchhoff
Thomas Horn
Jürgen E. Gschwend
Sebastian C. Schmid
author_sort Florestan J. Koll
title Evaluation of Pre-operative Biopsy, Surgical Procedures and Oncologic Outcomes in Upper Tract Urothelial Carcinoma (UTUC)
title_short Evaluation of Pre-operative Biopsy, Surgical Procedures and Oncologic Outcomes in Upper Tract Urothelial Carcinoma (UTUC)
title_full Evaluation of Pre-operative Biopsy, Surgical Procedures and Oncologic Outcomes in Upper Tract Urothelial Carcinoma (UTUC)
title_fullStr Evaluation of Pre-operative Biopsy, Surgical Procedures and Oncologic Outcomes in Upper Tract Urothelial Carcinoma (UTUC)
title_full_unstemmed Evaluation of Pre-operative Biopsy, Surgical Procedures and Oncologic Outcomes in Upper Tract Urothelial Carcinoma (UTUC)
title_sort evaluation of pre-operative biopsy, surgical procedures and oncologic outcomes in upper tract urothelial carcinoma (utuc)
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/b826d23d0bf04cf0810904123afdf502
work_keys_str_mv AT florestanjkoll evaluationofpreoperativebiopsysurgicalproceduresandoncologicoutcomesinuppertracturothelialcarcinomautuc
AT florestanjkoll evaluationofpreoperativebiopsysurgicalproceduresandoncologicoutcomesinuppertracturothelialcarcinomautuc
AT evameisenzahl evaluationofpreoperativebiopsysurgicalproceduresandoncologicoutcomesinuppertracturothelialcarcinomautuc
AT bernhardhaller evaluationofpreoperativebiopsysurgicalproceduresandoncologicoutcomesinuppertracturothelialcarcinomautuc
AT philippmaisch evaluationofpreoperativebiopsysurgicalproceduresandoncologicoutcomesinuppertracturothelialcarcinomautuc
AT philippmaisch evaluationofpreoperativebiopsysurgicalproceduresandoncologicoutcomesinuppertracturothelialcarcinomautuc
AT floriankirchhoff evaluationofpreoperativebiopsysurgicalproceduresandoncologicoutcomesinuppertracturothelialcarcinomautuc
AT thomashorn evaluationofpreoperativebiopsysurgicalproceduresandoncologicoutcomesinuppertracturothelialcarcinomautuc
AT jurgenegschwend evaluationofpreoperativebiopsysurgicalproceduresandoncologicoutcomesinuppertracturothelialcarcinomautuc
AT sebastiancschmid evaluationofpreoperativebiopsysurgicalproceduresandoncologicoutcomesinuppertracturothelialcarcinomautuc
_version_ 1718406223714320384